VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,079,719 | -10.1% | 188,767 | +0.6% | 0.20% | -7.9% |
| Q2 2023 | $5,649,900 | -8.5% | 187,642 | -1.7% | 0.21% | -13.7% |
| Q1 2023 | $6,172,929 | +9.8% | 190,817 | -2.8% | 0.25% | +6.0% |
| Q4 2022 | $5,623,865 | +12.1% | 196,227 | -5.6% | 0.23% | +0.9% |
| Q3 2022 | $5,015,000 | -16.2% | 207,889 | -4.9% | 0.23% | -11.5% |
| Q2 2022 | $5,983,000 | -28.9% | 218,529 | -0.4% | 0.26% | -19.1% |
| Q1 2022 | $8,417,000 | +37.1% | 219,469 | +14.5% | 0.32% | +44.0% |
| Q4 2021 | $6,139,000 | -3.2% | 191,660 | -11.0% | 0.22% | -10.4% |
| Q3 2021 | $6,345,000 | -14.0% | 215,298 | -0.8% | 0.25% | -14.0% |
| Q2 2021 | $7,377,000 | +98.7% | 217,092 | +34.7% | 0.29% | +26.4% |
| Q1 2021 | $3,713,000 | -44.6% | 161,189 | -13.4% | 0.23% | -11.8% |
| Q4 2020 | $6,706,000 | -2.4% | 186,166 | +6.2% | 0.26% | -11.2% |
| Q3 2020 | $6,868,000 | +4.3% | 175,376 | -2.3% | 0.30% | -0.7% |
| Q2 2020 | $6,582,000 | +77.3% | 179,450 | +11.3% | 0.30% | +50.0% |
| Q1 2020 | $3,713,000 | -19.0% | 161,189 | +3.0% | 0.20% | -13.2% |
| Q4 2019 | $4,584,000 | +8.0% | 156,569 | -1.4% | 0.23% | 0.0% |
| Q3 2019 | $4,243,000 | +4.5% | 158,871 | +0.0% | 0.23% | +2.2% |
| Q2 2019 | $4,060,000 | +20.0% | 158,836 | +5.2% | 0.22% | +14.4% |
| Q1 2019 | $3,384,000 | +140.7% | 150,945 | +126.3% | 0.20% | +112.0% |
| Q4 2018 | $1,406,000 | -19.4% | 66,688 | -29.2% | 0.09% | -5.2% |
| Q3 2018 | $1,744,000 | -15.5% | 94,193 | +1.9% | 0.10% | -19.8% |
| Q2 2018 | $2,063,000 | -7.6% | 92,448 | -9.0% | 0.12% | -4.7% |
| Q1 2018 | $2,232,000 | +23.5% | 101,553 | +30.5% | 0.13% | +29.6% |
| Q4 2017 | $1,808,000 | -2.3% | 77,809 | -3.5% | 0.10% | -3.9% |
| Q3 2017 | $1,851,000 | +14.0% | 80,621 | +9.6% | 0.10% | +10.9% |
| Q2 2017 | $1,624,000 | +4.9% | 73,590 | +8.5% | 0.09% | 0.0% |
| Q1 2017 | $1,548,000 | +71.8% | 67,841 | +57.5% | 0.09% | +64.3% |
| Q4 2016 | $901,000 | +76.7% | 43,070 | +123.5% | 0.06% | +75.0% |
| Q3 2016 | $510,000 | – | 19,271 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |